McElroy, S <br/><br/>
CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.  [electronic resource] 

 -  AAPS pharmSci  2000 
 - E33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1059 
<br/><br/><label>Standard No.: </label>10.1208/ps020433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cytochrome P-450 CYP2D6--genetics<br/>Debrisoquin--metabolism<br/>Dextromethorphan--metabolism<br/>Genotype<br/>Humans<br/>Phenotype<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic